Suzhou Basecare Medical Corporation Limited

Suzhou Basecare Medical Corporation Limitedverified

2170.HK

Price:

$2.28

Market Cap:

$566.49M

Suzhou Basecare Medical Corporation Limited, an investment holding company, engages in the research, development, manufacture, and provision of genetic testing solutions for assisted reproduction and sale of genetic testing devices and instruments in the People's Republic of China. The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides prenatal test kit products comprising CNV kits; postnatal test kit products ...[Read more]

Industry

Medical - Devices

IPO Date

2021-02-08

Stock Exchange

HKSE

Ticker

2170.HK

The PE Ratio as of December 2025 (TTM) for Suzhou Basecare Medical Corporation Limited (2170.HK) is -2.30

According to Suzhou Basecare Medical Corporation Limited’s latest financial reports and current stock price. The company's current PE Ratio is -2.30. This represents a change of -22.44% compared to the average of -2.97 of the last 4 quarters.

Suzhou Basecare Medical Corporation Limited (2170.HK) Historical PE Ratio (quarterly & annually)

How has 2170.HK PE Ratio performed in the past?

The mean historical PE Ratio of Suzhou Basecare Medical Corporation Limited over the last ten years is -12.11. The current -2.30 PE Ratio has changed 1.80% with respect to the historical average. Over the past ten years (40 quarters), 2170.HK's PE Ratio was at its highest in in the March 2019 quarter at 0. The PE Ratio was at its lowest in in the December 2020 quarter at -61.31.

Quarterly (TTM)
Annual

Average

-12.11

Median

-7.31

Minimum

-41.86

Maximum

-2.97

Suzhou Basecare Medical Corporation Limited (2170.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Suzhou Basecare Medical Corporation Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 42.23%

Maximum Annual PE Ratio = -2.97

Minimum Annual Increase = -70.33%

Minimum Annual PE Ratio = -41.86

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.97-2.26%
2023-3.04-58.46%
2022-7.31-27.42%
2021-10.0842.23%
2020-7.09-42.94%
2019-12.42-70.33%

Suzhou Basecare Medical Corporation Limited (2170.HK) Average PE Ratio

How has 2170.HK PE Ratio performed in the past?

The current PE Ratio of Suzhou Basecare Medical Corporation Limited (2170.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.44

5-year avg

-6.10

10-year avg

-12.11

Suzhou Basecare Medical Corporation Limited (2170.HK) PE Ratio vs. Peers

How is 2170.HK’s PE Ratio compared to its peers?

Suzhou Basecare Medical Corporation Limited’s PE Ratio is less than Beijing Biostar Pharms Co Ltd (0), less than Vincent Medical Holdings Limited (6.10), less than Guangdong Kanghua Healthcare Co., Ltd. (8.22), less than ClouDr Group Limited (-0.61), less than Austar Lifesciences Limited (12.96), greater than China Biotech Services Holdings Limited (-6.04), greater than Rainmed Medical Limited (-3.24), greater than Fusen Pharmaceutical Company Limited (-3.03), less than Yunkang Group Limited (-0.74), greater than MOG Holdings Limited (-4.36),

Build a custom stock screener for Suzhou Basecare Medical Corporation Limited (2170.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Suzhou Basecare Medical Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Suzhou Basecare Medical Corporation Limited (2170.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Suzhou Basecare Medical Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Suzhou Basecare Medical Corporation Limited's PE Ratio?

How is the PE Ratio calculated for Suzhou Basecare Medical Corporation Limited (2170.HK)?

What is the highest PE Ratio for Suzhou Basecare Medical Corporation Limited (2170.HK)?

What is the 3-year average PE Ratio for Suzhou Basecare Medical Corporation Limited (2170.HK)?

What is the 5-year average PE Ratio for Suzhou Basecare Medical Corporation Limited (2170.HK)?

How does the current PE Ratio for Suzhou Basecare Medical Corporation Limited (2170.HK) compare to its historical average?